Data / Form D filings / Lomond Therapeutics Holdings, Inc.
Lomond Therapeutics Holdings, Inc.: Form D filings
Lomond Therapeutics Holdings, Inc., a pharmaceuticals company in Dover, DE, filed 2 Form D notices with the SEC between 2024 and 2025. The latest, on February 11, 2025, reports $53.9 million sold of a $63.9 million offering to 28 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 8 THE GREEN, SUITE 8490, Dover, DE, 19901
- Phone
- (212) 739-6400
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1900520
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 11, 2025 | Amendment | $63,915,492 | $53,915,492 | $10,000,000 | 28 | Nov 1, 2024 | sec.gov |
| Nov 18, 2024 | New notice | $43,900,000 | $43,900,000 | 27 | Nov 1, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Carl Gordon | Director | |
| Iain Dukes | Executive Officer, Director | |
| Eddie Rodriguez | Director | |
| Nikolay Savchuk | Executive Officer, Director |
Every Form D from the week of Feb 10, 2025 · All recent filings in Delaware · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Lomond Therapeutics Holdings, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.